1. Advances in research of extracellular mechanisms underlying gemcitabine resistance in pancreatic cancer
   Zong-Ting Gu et al, 2021, World Chinese Journal of Digestology CrossRef
2. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells
   Lara Magni et al, 2021, Cells CrossRef
3. Pancreatic stellate cells - rising stars in pancreatic pathologies
   P Hrabák et al, 2021, Physiological Research CrossRef
4. Interrogating Matrix Stiffness and Metabolomics in Pancreatic Ductal Carcinoma Using an Openable Microfluidic Tumor-on-a-Chip
   Michael D. Mohan et al, 2024, ACS Applied Materials & Interfaces CrossRef
5. Protonation of Piezo1 Impairs Cell-Matrix Interactions of Pancreatic Stellate Cells
   Anna Kuntze et al, 2020, Frontiers in Physiology CrossRef
6. From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
   Chiara Bazzichetto et al, 2020, Cells CrossRef
7. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer
   Manoj Amrutkar et al, 2021, Cancers CrossRef
8. Role of Pancreatic Stellate Cell-Derived Exosomes in Pancreatic Cancer-Related Diabetes: A Novel Hypothesis
   Chamini J. Perera et al, 2021, Cancers CrossRef
9. The Metabolism Symbiosis Between Pancreatic Cancer and Tumor Microenvironment
   Ying Li et al, 2021, Frontiers in Oncology CrossRef
10. Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting
    Nardeen Perko et al, 2022, Cancers CrossRef
11. Stellate Cells in the Tumor Microenvironment
    David Roife et al, 2020, Tumor Microenvironment CrossRef
12. TGF-β1 Receptor Inhibitor SB525334 Attenuates the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells via the TGF-β1 Signaling Pathway
    Jung-Yoon Heo et al, 2021, Biomedicines CrossRef